HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roxan Ara Selected Research

Hypoxia (Hypoxemia)

1/2016Anti-VEGFR2 driven nuclear translocation of VEGFR2 and acquired malignant hallmarks are mutation dependent in glioblastoma.
1/2016Chimeric Mouse model to track the migration of bone marrow derived cells in glioblastoma following anti-angiogenic treatments.
12/2015Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roxan Ara Research Topics

Disease

13Neoplasms (Cancer)
01/2021 - 12/2015
7Glioblastoma (Glioblastoma Multiforme)
01/2021 - 01/2016
3Neoplasm Metastasis (Metastasis)
10/2019 - 01/2017
3Hypoxia (Hypoxemia)
01/2016 - 12/2015
2Bone Diseases (Bone Disease)
01/2021 - 08/2020
2Glioma (Gliomas)
01/2021 - 10/2018
2Breast Neoplasms (Breast Cancer)
01/2017 - 01/2017
1Stroke (Strokes)
06/2021
1Bone Resorption
08/2020
1Disease Progression
10/2019
1Inflammation (Inflammations)
01/2017

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2016
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2018 - 12/2015
3CytokinesIBA
08/2020 - 01/2017
3vatalanib (PTK787)IBA
10/2018 - 01/2016
3HET0016IBA
09/2017 - 01/2017
220-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
09/2017 - 01/2017
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2017 - 01/2017
1Radioisotopes (Radionuclides)IBA
10/2019
1Bevacizumab (Avastin)FDA Link
10/2018
1Interleukin-8 (Interleukin 8)IBA
10/2018
1EndoglinIBA
10/2017
1ChemokinesIBA
10/2017
1Periodic AcidIBA
09/2017
1Peptides (Polypeptides)IBA
01/2017
1Laminin (Merosin)IBA
01/2017
1Metalloproteases (Metalloproteinases)IBA
01/2017
1ChromatinIBA
01/2016
1Therapeutic UsesIBA
01/2016
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2016
15- (3- methoxy- 4- ((4- methoxybenzyl)oxy)benzyl)pyrimidine- 2,4- diamineIBA
12/2015

Therapy/Procedure

9Therapeutics
01/2021 - 12/2015
1Intravenous Administration
06/2021
1Immunomodulation
01/2021
1Immunotherapy
01/2021
1Aftercare (After-Treatment)
01/2016